Teasing Apart Multiple Biologic Failure in Psoriasis, PsA
'Tough-to-treat psoriasis remains a challenge despite newer therapies ... Why do we still have this sub-population of patients who seem to be refractory?'
Source: medscape.com
Page 11 - Oint Inflammation News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Oint Inflammation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Oint Inflammation Today - Breaking & Trending Today
Study finds doubled risk of fractures in patients with acute calcium pyrophosphate crystal arthritis
Researchers will present the first-ever study of fractures and calcium pyrophosphate deposition disease at ACR Convergence 2023, the American College of Rheumatology's annual meeting.
Source: news-medical.net
JAK Inhibitor Effects in RA Confirmed in Real-World Study
The safety and efficacy of tofacitinib, baricitinib, peficitinib, and upadacitinib were similar in a multicenter study of more than 600 adults with rheumatoid arthritis.
Source: medscape.com
FDA Approves Abatacept for Pediatric Patients With Psoriatic Arthritis
As many as 5% of pediatric patients with juvenile idiopathic arthritis are estimated to have juvenile PsA.
Source: medscape.com
Study Finds Ruxolitinib Effective, Safe for Children With AD
There were no significant safety signals in the younger pediatric population, and 'no treatment-emergent adverse events suggestive of systemic JAK inhibition,' Dr Lawrence Eichenfield said.
Source: medscape.com